| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5949992 | Atherosclerosis | 2011 | 7 Pages |
Abstract
Nicorandil exerts its anti-atherogenic effect by mechanisms different from those of statins. Long-term nicorandil treatment is a potentially suitable second-line prevention therapy for patients with coronary artery disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yasuhiro Izumiya, Sunao Kojima, Shinobu Kojima, Satoshi Araki, Hiroki Usuku, Junichi Matsubara, Kenji Sakamoto, Kenichi Tsujita, Yasuhiro Nagayoshi, Koichi Kaikita, Seigo Sugiyama, Hisao Ogawa,